In conclusion, we propose that AMPK couples the inhibition of mitochondrial oxidative phosphorylation to Kv1.5 channel inhibition in pulmonary arterial myocytes, which may contribute to the regulation by AMPK of smooth muscle proliferation and thus to the development of pulmonary hypertension. The gene discussed is PRKAA1; the disease is pulmonary hypertension.